And I would not, the FDA has raised some concerns that are going to be fundamentally impossible for MSB to fix, based on the nature of stem cells.
It will not only be their graft vs host product that will have these issues, their entire portfolio is based on stem cell derived products.
I'd be very reluctant to buy in at this stage. Or any future stage to be honest.
Anyone else buy in after todays dip/crash?, page-55
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.18 | $2.392M | 2.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 19564 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 28296 | 7 |
View Market Depth
| Last trade - 11.24am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |